Tumor-infiltrating lymphocytes in patients with renal-cell carcinoma.
Finke
J H
JH
Department of Immunology, Cleveland Clinic Foundation, Ohio 44106.
Tubbs
R
R
Connelly
B
B
Pontes
E
E
Montie
J
J
D002292:Carcinoma, Renal Cell / Q000276:immunology*; D002478:Cells, Cultured; D003602:Cytotoxicity, Immunologic; D006801:Humans; D007376:Interleukin-2 / Q000502:physiology; D007680:Kidney Neoplasms / Q000276:immunology*; D007694:Killer Cells, Natural / Q000276:immunology; D008213:Lymphocyte Activation; D010641:Phenotype; D013601:T-Lymphocytes / Q000276:immunology* / Q000473:pathology; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D006377:T-Lymphocytes, Helper-Inducer / Q000276:immunology; D050378:T-Lymphocytes, Regulatory / Q000276:immunology
D007376:Interleukin-2